Screener
CONMED CNMD CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Net cash provided by operating activities | 50,567 | 70,668 |
| Cash flows from investing activities: | ||
| Proceeds from sale of product offerings | 21,500 | — |
| Purchases of property, plant and equipment | (5,826) | (9,508) |
| Other | — | 850 |
| Net cash provided by (used in) investing activities | 15,674 | (8,658) |
| Cash flows from financing activities: | ||
| Payments on term loan | — | (54,821) |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's capex?
- CONMED (CNMD) reported capex of $2.93M in Q2 2026.
- How has CONMED's capex changed year-over-year?
- CONMED's capex decreased by 48.8% year-over-year, from $5.73M to $2.93M.
- What is the long-term trend for CONMED's capex?
- Over 4 years (2021 to 2025), CONMED's capex has grown at a 7.4% compound annual growth rate (CAGR), from $14.87M to $19.81M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about CONMED's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude